Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
成人和青少年慢性特發性蕁麻疹患者中利格利珠單抗的療效和安全性:兩項3期隨機對照試驗結果。
Lancet 2024-04-05
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective.
新型具心血管效應的抗糖尿病藥物低接受度的原因-家庭醫生的觀點。
J Clin Med 2024-03-30